Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria

BACKGROUND: Chloroquine has been recommended for Plasmodium vivax infections for >60 years, but resistance is increasing. To guide future therapies, the cumulative benefits of using slowly eliminated (chloroquine) vs rapidly eliminated (artesunate) antimalarials, and the risks and benefits of add...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Chu, Cindy S, Phyo, Aung Pyae, Lwin, Khin Maung, Win, Htun Htun, San, Thida, Aung, Aye Aye, Raksapraidee, Rattanaporn, Carrara, Verena I, Bancone, Germana, Watson, James, Moore, Kerryn A, Wiladphaingern, Jacher, Proux, Stéphane, Sriprawat, Kanlaya, Winterberg, Markus, Cheah, Phaik Yeong, Chue, Amy L, Tarning, Joel, Imwong, Mallika, Nosten, François, White, Nicholas J
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Articles and Commentaries
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206118/
https://ncbi.nlm.nih.gov/pubmed/29889239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy319
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items